Log In
BCIQ
Print this Print this
 

RC18

  Manage Alerts
Collapse Summary General Information
Company Yantai Rongchang Pharmaceutical Co. Ltd.
DescriptionRecombinant human B lymphocyte stimulating factor receptor-antibody fusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today